Can the Onset of Type 2 Diabetes Be Delayed by a Group-Based Lifestyle Intervention in Women with Prediabetes following Gestational Diabetes Mellitus (GDM)? Findings from a Randomized Control Mixed Methods Trial
Table 3
Improvement from baseline to EOP (intervention group only).
Variables assessed at EOP
Baseline mean (sd)
EOP mean (sd)
Improvement (sd)
value
95% confidence interval for mean improvement
Weight (kg)
90.71 (13.30)
88.09 (13.98)
2.62 (2.87)
0.006
(0.88, 4.36)
BMI
34.98 (4.52)
33.93 (4.57)
1.04 (1.55)
0.03
(0.10, 1.98)
Waist circumference (cm)
112.3 (14.69)
107.63 (18.13)
4.68 (5.11)
0.016
(1.25, 8.11)
Med diet score
6.92 (2.29)
7.84 (3.21)
0.92 (2.53)
0.21
(−2.45, 0.60)
Estimated METmax
8.17 (1.36)
9.59 (1.58)
1.42 (0.87)
0.001
(0.86, 1.97)
Total cholesterol
5.08 (0.68)
4.40 (0.46)
0.68 (0.80)
0.013
(0.13, 1.22)
Triglycerides
1.23 (0.59)
1.32 (0.68)
−0.09 (0.48)
0.54
(−0.41, 0.23)
HDL cholesterol
1.41 (0.35)
1.21 (0.28)
−0.20 (0.25)
0.02
(−0.36, −0.03)
LDL cholesterol
3.07 (0.70)
2.60 (0.43)
0.47 (0.60)
0.03
(0.03, 0.90)
, . On these variables higher scores at EOP represent an improvement in function. Thus improvement is calculated by subtracting baseline score from EOP score. On all other variables a lower score at EOP represents improvement; therefore, improvement is calculated by subtracting EOP score from baseline score.
